Member Info for Heimdal

Chart wise we are currently forming the handle of a large bullish cup and handle pattern. I expect a breakout shortly from the current consolidation phase with a price target of around $1.80. Breakout point: $1.25

That is a very common problem with AAstocks, The.Italian. Just hit the F5 key.

Happy to pick up a few more @ 70c today - like taking candy from a baby lol

Indeed, but we are still better off than if we had followed Charliedingbat's advise (way back) and loaded up on AMC and MVMD..

Yeah right, still a long way to go.. However, very positive with the breakout on high vol

(today was the highest vol since 27/9/2022 - 35.6m on the old scale). Probably pre-approval accumulation.

Buy depth were building yesterday with 700k v/s only 20k on the sell side just before lunch.

I noticed a few larger buy orders by SDICS (a new player on this stock).

Lots of off-screen buying today.

Quam Sec, Phillip, Zinvest, Prudential, Futu Sec, Valuable, Bri Smart, BOCI and CMBI all in the BID Queue at close,

so a few different punters but no sign of Citigroup today (?maybe off screen accumulation).

Chart wise it is looking good after the solid close @ 98c, maybe closing the $1.44-1.52 chart gap tomorrow?

Trend reversal noted with higher lows and higher highs since primo DEC 2024.

Volume picking up.

Citigroup still in the market. IB also noted today.

Decent vol today (5X daily average).

Slow STC on the chart indicating further gains to follow next week.

Potential game changing NDA approval expected (w i t h i n) 12 months from the submission date,

so maybe some early approval speculation by certain investors? Maybe something going on in the background?

Good to hear you are still holding all your shares Bignose.

Hopefully China will come through within the next year with a major SP bounce to follow

Citigroup is still in the market. Clear accumulation around the 47c level

Hi Bothwell, holding just shy of 500,000 for the long haul. I guess Bignose sold out on OCT 7 last year @ 42c - not too many large HSBC traders around lol. Citigroup still in the market and BUY depth building (currently 450k on the BID Queue v/s 10k on the sell side). Hopefully China will deliver down the track - could be a major game changer considering our very low MCap of just USD 13m. We will see how it all pans out - JM keeping the lights on for now..

Greetings all, Citigroup did all the buying today. 16 unfilled buy order by Citigroup still in place at close for a total of 460,000 shares @ 47c

Agree, good to see the end of JO. Did she add much value? She never had much skin in the game unlike JG and JM

Happy to see some new blood on the board but would have preferred a heavy hitter like Dr Wyllie or Dr Zhavoronkov both with solid industry experience, oh well

I doubt it is a simple pump and dump but rather accumulation by Haitong Securities during the past 3 weeks.

It is not uncommon for prof investors to sell a few shares during the accumulation phase in order to keep

the sp within a low trading band (fx. buy 40-50,000 then quickly dump 10,000..).

The share was sold down to a historical low of just 25c on very low volume so it should recover on low vol.

News on the NDA submission is not far away now and should get the sp moving.

I noticed an erratic 500k sell order @ 72c about 4-5 weeks ago, was that you Bignose, you are a HSBC trader right?

"7/6/23 0.59 hkd the low." Not correct, Ripley. I picked up another 50,000 shares @ 25c - now in safe hands.. lol

Interesting accumulation during the last few weeks by Haitong Securities

Futu Securities driving the rise today. These fellas are also the prime movers on the sustained New Ray Medic (6108) rally from 14c on April 6 to HK$2.51 today. Will 575 be the next 6108 runner?

Major rally in HK pharma stocks Bignose
Today Kaisa Health top the HK market - up 75%, # 2 is Uni Health with + 38%
New Ray Medic up +600% since last week on no news.. could this be the rally we all need to get back on track?

https://news.rthk.hk/rthk/en/component/k2/1642368-20220404.htm?fbclid=IwAR3L6Dwz0MaVPmQqOggDRatbytIFK86-V1zsgsDxuamSalFyDM_YOjklnEM

Indeed, time will tell. Maybe after all the BOD will manage to secure a superior US deal to the one Alquime noted in one of his 1,141 posts (exclusively on PLE): "Back in ancient times (2007), PLE concluded an exclusive US licence with Sciele on what might charitably be described as generous terms: no upfront (but $7m equity purchase, around 5.6% of the company); no development costs; a $7m approval milestone, 10% royalty and $23m in commercial milestones (with ludicrously high annual sales triggers)." Time will tell.

A potential $17m cash injection later this year would represent almost 50% of the current MCap and should have some positive impact on the sp.

Thanks Italian. Very interesting and potential significant development. Not sure why this is not highlighted up front?

WE ARE HIRING: TECHNICAL PROJECT MANAGER

Currently, we are looking for talented and motivated Technical project managers.

Responsibilities:

- Coordination of the SaaS development project team
- Adjusting development methodologies and workflow to improve speed and reliability
- Supporting tasks throughout whole lifecycle, from analysis to deployment
- Managing, adjusting and approving any changes in project scope, schedule, design and/or budget
- Identifying and mitigating potential risks
- Managing the relationship and communication with the client and stakeholders
- Defining metrics and criteria for performance, testing and product acceptance
- Writing specifications and technical documentation

Requirements

- Experience in program or project management
- Experience managing group goals, driving timelines, and organizing/presenting data
- Experience in the implementation of Agile development methodologies
- Communication skills in English
- Knowledge of cost dev / jobs-to-be-done methodologies, ability to form product hypotheses and understand how to test them and make decisions based on them;
- Ability to use analytics services (at least one): Google Analytics, Amplitude, Appsflyer. AppMetrica;
- Understanding of the main marketing metrics: CPI, CPA, Arpu;
- Experience in working and building end-to-end analytics

Tools we use to work efficiently:

- Jira, Slack, Confluence, Miro, Figma

What we offer:

- Work in innovative industry and emerging market
- Competitive compensation depending on experience and skills
- Friendly, creative and cohesive team

I have suffered severely with (PE), and it has been a complete ruin to my love life and relationships. I have been divorced 4 times as a result of my (PE) problems. I need help and I am willing to do whatever I can to possibly be treated for this issue.

https://www.morarimedical.com/

Thanks Bignose, indeed too many mechanical problems with the Td5 engine so I had to change it to a 4 cyl and since then no problems but do miss the sound of the old Td5 motor.

Dougie, we hit 79c in Dec 2016 just on the GB roll out news and we have come a long way since then with
OTC approval in EU, Israel and Balkan license agreements, roll out in Taiwan, HK and Macao, China clinical trials
to commence in China shortly, Phase II completed in USA, DVP sp surge etc.. so if we can manage to kick a few goals
and tap into a rebounding HK market with some positive announcements I think $1 is certainly achievable within the next
year or two. There will most likely be further developments in the growing longevity sector which could also assist in boosting the SP. Important to keep in mind that our current MCap is only 32m squid (ie under shell value) so the potential is there to go well above HK$1 if things fall into place. Management have significant skin in the game and I am sure they do their utmost to kick things along. I can smell the bacon